No definition available.
Carcinoma in situ of breast, intraductal
CD2_INSITU_BREAST_INTRADUCTAL_EXALLC
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
---|---|
Phenotype data |
|
1. Apply sex-specific ruleonly females |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
Extra metadata
Similar endpoints
↥List of similar endpoints to Carcinoma in situ of breast, intraductal based on the number of shared cases.
Similar with more cases:
- Carcinoma in situ of breast, intraductal
- In situ neoplasms
- In situ neoplasms
- Neoplasms
- Any operation in hilmo
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | |||
Whole population | 13450 | 13450 | - |
Only index persons | 13149 | 13149 | - |
Unadjusted period prevalence (%) | |||
Whole population | 0.39 | 0.39 | - |
Only index persons | 0.48 | 0.48 | - |
Median age at first event (years) | |||
Whole population | - | 60.44 | - |
Only index persons | - | 60.43 | - |
-FinnGen-
Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | 2651 | 2651 | - |
Unadjusted period prevalence (%) | 1.04 | 1.04 | - |
Median age at first event (years) | 60.21 | 60.21 | - |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
Mortality – FinRegistry
↥Association
Association between endpoint CD2_INSITU_BREAST_INTRADUCTAL_EXALLC and mortality.
Females
Parameter | HR [95% CI] | p-value |
---|---|---|
CD2_INSITU_BREAST_INTRADUCTAL_EXALLC | 1.095 [0.98, 1.22] | 0.103 |
Birth year | 0.994 [0.98, 1.0] | 0.148 |
During the follow-up period (1.1.1998 — 31.12.2019), 1321 out of 11719 females with CD2_INSITU_BREAST_INTRADUCTAL_EXALLC died.
Males
No dataMortality risk
Mortality risk for people of age
years, who have CD2_INSITU_BREAST_INTRADUCTAL_EXALLC.N-year risk | Females | Males |
---|---|---|
1 | 0.11% | No data |
5 | 0.651% | No data |
10 | 1.528% | No data |
15 | 2.962% | No data |
20 | 4.977% | No data |
Relationships between endpoints
↥Index endpoint: CD2_INSITU_BREAST_INTRADUCTAL_EXALLC – Carcinoma in situ of breast, intraductal
GWS hits: 5